Jeremy Lavine is an Ophthalmology physician. OpenAlex indexes 106 publications with 1,480 citations (h-index 23).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Cleveland Clinic
9500 Euclid Avenue
Cleveland, OH 44195
Telephone
216-444-5892Registry record last updated 26 May 2018.
Industry payments
8 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Genentech USA, Inc.Program year20257 payments
- Regeneron Pharmaceuticals, Inc.Program year20251 payment
- Neurotech Pharmaceuticals, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
59.9%Vascular Endothelial Growth Factor Inhibitor59.9%Aflibercept68%Bevacizumab33%Part B, office-administered≥17 patientsSensory organs
24%Corticosteroid12.6%Prednisolone Acetate100%Part D≥13 patientsProstaglandin Analog6.1%Latanoprost100%Part D<11 patients+ 1 more class in this area
Musculoskeletal
11.8%Cyclooxygenase Inhibitor11.8%Ketorolac Tromethamine100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- The role of myeloid cell heterogeneity during spontaneous choroidal neovascularization in Vldlr knockout mice
Journal of Neuroinflammation
2025 - <i>Adrb2</i> Expression in Ocular-Infiltrating Macrophages Is Necessary for Interleukin-6 Expression and Choroidal Neovascularization
Investigative Ophthalmology & Visual Science
2025 - Retinal perivascular macrophages regulate immune cell infiltration during neuroinflammation in mouse models of ocular disease
Journal of Clinical Investigation
2024
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Emily Chew, MD
National Eye Institute
Robert Weinreb, MD
University of California San Diego
Harry Quigley, MD
Johns Hopkins University School of Medicine
Joel Schuman, MD
Wills Eye Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”